Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin
Identifieur interne : 000918 ( Istex/Corpus ); précédent : 000917; suivant : 000919Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin
Auteurs : Roger A. Barthelson ; Thomas Potter ; Frank H. ValoneSource :
- Cellular Immunology [ 0008-8749 ] ; 1990.
English descriptors
- Teeft :
- Academic press, Active form, Assay, Autoradiograph, Barthelson, Bioassay, Buffer control, Cell immunology, Cell proteins, Cell supernatants, Collaborative research, Complex effects, Cytokine release, Densitometric measurement, Different concentrations, Different pair, Elisa, Escherichia coli, Human monocytes, Human monocytic leukemia cell line, Immunol, Microtiter plates, Monoclonal antibodies, Monocyte, Palo alto, Precursor, Proliferation assay, Rabbit antiserum, Radioimmune assay, Relative staining, Releaseby, Separate series, Sigma chemical, Significant increase, Small difference, Stable cell line, Supernatant, Syntex corp, Total absorbance, Valone.
Abstract
Abstract: The capacity to stimulate cytokine release may be important to the long-term effects of platelet-activating factor (PAF), which has a very short half-life. Previous studies have shown that PAF stimulates interleukin 1 (IL-1) release by human monocytes. IL-1 and other cytokines produced in response to PAF may be important to the long-term effects of this short-lived lipid. The THP-1 human monocytic leukemia cell line, was used to study the mechanism by which PAF stimulates IL-1 release. PAF stimulates the release of IL-1 β activity into THP-1 cell supernatants with a multiphasic dose-response curve very similar to that for monocytes. When THP-1 cells are treated with PAF and LPS in combination, these two stimuli interact synergistically to greatly increase the release of IL-1 activity. To assess the effect of PAF on IL-1 β synthesis, THP-1 cell pellet proteins were separated by SDS-PAGE, blotted, and immunostained to detect IL-1β. Immunostaining revealed that PAF increases intracellular IL-1 β precursor and that the combination of PAF and LPS increases IL-1 β precursor synergistically. PAF increases IL-1 β release mainly by increasing IL-1 β synthesis.
Url:
DOI: 10.1016/0008-8749(90)90069-4
Links to Exploration step
ISTEX:86E1DF7906750C6C813B33AC7C8CCAF813C35A4CLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin</title>
<author><name sortKey="Barthelson, Roger A" sort="Barthelson, Roger A" uniqKey="Barthelson R" first="Roger A." last="Barthelson">Roger A. Barthelson</name>
<affiliation><mods:affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>The University of California, San Francisco, California 94143 USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Potter, Thomas" sort="Potter, Thomas" uniqKey="Potter T" first="Thomas" last="Potter">Thomas Potter</name>
<affiliation><mods:affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>The University of California, San Francisco, California 94143 USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Valone, Frank H" sort="Valone, Frank H" uniqKey="Valone F" first="Frank H." last="Valone">Frank H. Valone</name>
<affiliation><mods:affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>The University of California, San Francisco, California 94143 USA</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:86E1DF7906750C6C813B33AC7C8CCAF813C35A4C</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1016/0008-8749(90)90069-4</idno>
<idno type="url">https://api.istex.fr/document/86E1DF7906750C6C813B33AC7C8CCAF813C35A4C/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000918</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000918</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin</title>
<author><name sortKey="Barthelson, Roger A" sort="Barthelson, Roger A" uniqKey="Barthelson R" first="Roger A." last="Barthelson">Roger A. Barthelson</name>
<affiliation><mods:affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>The University of California, San Francisco, California 94143 USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Potter, Thomas" sort="Potter, Thomas" uniqKey="Potter T" first="Thomas" last="Potter">Thomas Potter</name>
<affiliation><mods:affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>The University of California, San Francisco, California 94143 USA</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Valone, Frank H" sort="Valone, Frank H" uniqKey="Valone F" first="Frank H." last="Valone">Frank H. Valone</name>
<affiliation><mods:affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>The University of California, San Francisco, California 94143 USA</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Cellular Immunology</title>
<title level="j" type="abbrev">YCIMM</title>
<idno type="ISSN">0008-8749</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1990">1990</date>
<biblScope unit="volume">125</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="142">142</biblScope>
<biblScope unit="page" to="150">150</biblScope>
</imprint>
<idno type="ISSN">0008-8749</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0008-8749</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Academic press</term>
<term>Active form</term>
<term>Assay</term>
<term>Autoradiograph</term>
<term>Barthelson</term>
<term>Bioassay</term>
<term>Buffer control</term>
<term>Cell immunology</term>
<term>Cell proteins</term>
<term>Cell supernatants</term>
<term>Collaborative research</term>
<term>Complex effects</term>
<term>Cytokine release</term>
<term>Densitometric measurement</term>
<term>Different concentrations</term>
<term>Different pair</term>
<term>Elisa</term>
<term>Escherichia coli</term>
<term>Human monocytes</term>
<term>Human monocytic leukemia cell line</term>
<term>Immunol</term>
<term>Microtiter plates</term>
<term>Monoclonal antibodies</term>
<term>Monocyte</term>
<term>Palo alto</term>
<term>Precursor</term>
<term>Proliferation assay</term>
<term>Rabbit antiserum</term>
<term>Radioimmune assay</term>
<term>Relative staining</term>
<term>Releaseby</term>
<term>Separate series</term>
<term>Sigma chemical</term>
<term>Significant increase</term>
<term>Small difference</term>
<term>Stable cell line</term>
<term>Supernatant</term>
<term>Syntex corp</term>
<term>Total absorbance</term>
<term>Valone</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: The capacity to stimulate cytokine release may be important to the long-term effects of platelet-activating factor (PAF), which has a very short half-life. Previous studies have shown that PAF stimulates interleukin 1 (IL-1) release by human monocytes. IL-1 and other cytokines produced in response to PAF may be important to the long-term effects of this short-lived lipid. The THP-1 human monocytic leukemia cell line, was used to study the mechanism by which PAF stimulates IL-1 release. PAF stimulates the release of IL-1 β activity into THP-1 cell supernatants with a multiphasic dose-response curve very similar to that for monocytes. When THP-1 cells are treated with PAF and LPS in combination, these two stimuli interact synergistically to greatly increase the release of IL-1 activity. To assess the effect of PAF on IL-1 β synthesis, THP-1 cell pellet proteins were separated by SDS-PAGE, blotted, and immunostained to detect IL-1β. Immunostaining revealed that PAF increases intracellular IL-1 β precursor and that the combination of PAF and LPS increases IL-1 β precursor synergistically. PAF increases IL-1 β release mainly by increasing IL-1 β synthesis.</div>
</front>
</TEI>
<istex><corpusName>elsevier</corpusName>
<keywords><teeft><json:string>monocyte</json:string>
<json:string>barthelson</json:string>
<json:string>valone</json:string>
<json:string>autoradiograph</json:string>
<json:string>precursor</json:string>
<json:string>elisa</json:string>
<json:string>releaseby</json:string>
<json:string>immunol</json:string>
<json:string>bioassay</json:string>
<json:string>assay</json:string>
<json:string>human monocytes</json:string>
<json:string>supernatant</json:string>
<json:string>cell immunology</json:string>
<json:string>sigma chemical</json:string>
<json:string>proliferation assay</json:string>
<json:string>buffer control</json:string>
<json:string>palo alto</json:string>
<json:string>collaborative research</json:string>
<json:string>academic press</json:string>
<json:string>microtiter plates</json:string>
<json:string>cell supernatants</json:string>
<json:string>different concentrations</json:string>
<json:string>human monocytic leukemia cell line</json:string>
<json:string>stable cell line</json:string>
<json:string>rabbit antiserum</json:string>
<json:string>escherichia coli</json:string>
<json:string>total absorbance</json:string>
<json:string>monoclonal antibodies</json:string>
<json:string>radioimmune assay</json:string>
<json:string>different pair</json:string>
<json:string>significant increase</json:string>
<json:string>syntex corp</json:string>
<json:string>cell proteins</json:string>
<json:string>densitometric measurement</json:string>
<json:string>separate series</json:string>
<json:string>complex effects</json:string>
<json:string>active form</json:string>
<json:string>small difference</json:string>
<json:string>cytokine release</json:string>
<json:string>relative staining</json:string>
</teeft>
</keywords>
<author><json:item><name>Roger A. Barthelson</name>
<affiliations><json:string>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</json:string>
<json:string>The University of California, San Francisco, California 94143 USA</json:string>
</affiliations>
</json:item>
<json:item><name>Thomas Potter</name>
<affiliations><json:string>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</json:string>
<json:string>The University of California, San Francisco, California 94143 USA</json:string>
</affiliations>
</json:item>
<json:item><name>Frank H. Valone</name>
<affiliations><json:string>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</json:string>
<json:string>The University of California, San Francisco, California 94143 USA</json:string>
</affiliations>
</json:item>
</author>
<articleId><json:string>90900694</json:string>
</articleId>
<arkIstex>ark:/67375/6H6-9VH08SWM-6</arkIstex>
<language><json:string>eng</json:string>
</language>
<originalGenre><json:string>Full-length article</json:string>
</originalGenre>
<abstract>Abstract: The capacity to stimulate cytokine release may be important to the long-term effects of platelet-activating factor (PAF), which has a very short half-life. Previous studies have shown that PAF stimulates interleukin 1 (IL-1) release by human monocytes. IL-1 and other cytokines produced in response to PAF may be important to the long-term effects of this short-lived lipid. The THP-1 human monocytic leukemia cell line, was used to study the mechanism by which PAF stimulates IL-1 release. PAF stimulates the release of IL-1 β activity into THP-1 cell supernatants with a multiphasic dose-response curve very similar to that for monocytes. When THP-1 cells are treated with PAF and LPS in combination, these two stimuli interact synergistically to greatly increase the release of IL-1 activity. To assess the effect of PAF on IL-1 β synthesis, THP-1 cell pellet proteins were separated by SDS-PAGE, blotted, and immunostained to detect IL-1β. Immunostaining revealed that PAF increases intracellular IL-1 β precursor and that the combination of PAF and LPS increases IL-1 β precursor synergistically. PAF increases IL-1 β release mainly by increasing IL-1 β synthesis.</abstract>
<qualityIndicators><score>8.215</score>
<pdfWordCount>4043</pdfWordCount>
<pdfCharCount>22671</pdfCharCount>
<pdfVersion>1.3</pdfVersion>
<pdfPageCount>9</pdfPageCount>
<pdfPageSize>468 x 720 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractWordCount>181</abstractWordCount>
<abstractCharCount>1179</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin</title>
<pmid><json:string>2293896</json:string>
</pmid>
<pii><json:string>0008-8749(90)90069-4</json:string>
</pii>
<genre><json:string>research-article</json:string>
</genre>
<host><title>Cellular Immunology</title>
<language><json:string>unknown</json:string>
</language>
<publicationDate>1990</publicationDate>
<issn><json:string>0008-8749</json:string>
</issn>
<pii><json:string>S0008-8749(00)X0294-8</json:string>
</pii>
<volume>125</volume>
<issue>1</issue>
<pages><first>142</first>
<last>150</last>
</pages>
<genre><json:string>journal</json:string>
</genre>
</host>
<namedEntities><unitex><date><json:string>1990</json:string>
</date>
<geogName></geogName>
<orgName><json:string>American Lung Association of California</json:string>
<json:string>University of California San Francisco</json:string>
<json:string>American Type Culture Collection, Rockville, MD</json:string>
<json:string>Advanced Magnetics Inc.</json:string>
<json:string>Bachem</json:string>
<json:string>Genentech</json:string>
<json:string>VeteransAdministration Medical Center</json:string>
<json:string>CISTRON Biotechnology</json:string>
<json:string>University of California, San Francisco</json:string>
<json:string>Sigma Chemical Co.</json:string>
<json:string>Collaborative Research, Bedford, MA</json:string>
<json:string>Syntex Corp., Palo Alto</json:string>
<json:string>AI</json:string>
<json:string>American Cancer Society</json:string>
<json:string>Veterans Administration</json:string>
<json:string>National Institutes of Health</json:string>
</orgName>
<orgName_funder><json:string>AI</json:string>
<json:string>American Cancer Society</json:string>
<json:string>Veterans Administration</json:string>
<json:string>National Institutes of Health</json:string>
</orgName_funder>
<orgName_provider></orgName_provider>
<persName><json:string>A. C. Allison</json:string>
<json:string>Robert Cohen</json:string>
<json:string>Barthelson</json:string>
<json:string>Nancy Ruis</json:string>
<json:string>Anthony Allison</json:string>
<json:string>Sanjay Rajpura</json:string>
</persName>
<placeName><json:string>IL</json:string>
<json:string>Torrance</json:string>
<json:string>Pine Brook</json:string>
<json:string>IN</json:string>
<json:string>Richmond</json:string>
<json:string>Mannheim</json:string>
<json:string>Boston</json:string>
<json:string>San Francisco</json:string>
<json:string>CA</json:string>
<json:string>MA</json:string>
<json:string>NJ</json:string>
<json:string>Cambridge</json:string>
<json:string>Indianapolis</json:string>
<json:string>Arlington Heights</json:string>
</placeName>
<ref_url></ref_url>
<ref_bibl><json:string>[1251]</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark><json:string>ark:/67375/6H6-9VH08SWM-6</json:string>
</ark>
<categories><wos><json:string>1 - science</json:string>
<json:string>2 - immunology</json:string>
<json:string>2 - cell biology</json:string>
</wos>
<scienceMetrix><json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - immunology</json:string>
</scienceMetrix>
<scopus><json:string>1 - Life Sciences</json:string>
<json:string>2 - Immunology and Microbiology</json:string>
<json:string>3 - Immunology</json:string>
</scopus>
<inist><json:string>1 - sciences appliquees, technologies et medecines</json:string>
<json:string>2 - sciences biologiques et medicales</json:string>
<json:string>3 - sciences medicales</json:string>
</inist>
</categories>
<publicationDate>1990</publicationDate>
<copyrightDate>1990</copyrightDate>
<doi><json:string>10.1016/0008-8749(90)90069-4</json:string>
</doi>
<id>86E1DF7906750C6C813B33AC7C8CCAF813C35A4C</id>
<score>1</score>
<fulltext><json:item><extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/86E1DF7906750C6C813B33AC7C8CCAF813C35A4C/fulltext/pdf</uri>
</json:item>
<json:item><extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/86E1DF7906750C6C813B33AC7C8CCAF813C35A4C/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/86E1DF7906750C6C813B33AC7C8CCAF813C35A4C/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin</title>
</titleStmt>
<publicationStmt><authority>ISTEX</authority>
<publisher>ELSEVIER</publisher>
<availability><p>ELSEVIER</p>
</availability>
<date>1990</date>
</publicationStmt>
<sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin</title>
<author xml:id="author-0000"><persName><forename type="first">Roger A.</forename>
<surname>Barthelson</surname>
</persName>
<affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</affiliation>
<affiliation>The University of California, San Francisco, California 94143 USA</affiliation>
</author>
<author xml:id="author-0001"><persName><forename type="first">Thomas</forename>
<surname>Potter</surname>
</persName>
<affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</affiliation>
<affiliation>The University of California, San Francisco, California 94143 USA</affiliation>
</author>
<author xml:id="author-0002"><persName><forename type="first">Frank H.</forename>
<surname>Valone</surname>
</persName>
<affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</affiliation>
<affiliation>The University of California, San Francisco, California 94143 USA</affiliation>
</author>
<idno type="istex">86E1DF7906750C6C813B33AC7C8CCAF813C35A4C</idno>
<idno type="DOI">10.1016/0008-8749(90)90069-4</idno>
<idno type="PII">0008-8749(90)90069-4</idno>
<idno type="ArticleID">90900694</idno>
</analytic>
<monogr><title level="j">Cellular Immunology</title>
<title level="j" type="abbrev">YCIMM</title>
<idno type="pISSN">0008-8749</idno>
<idno type="PII">S0008-8749(00)X0294-8</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1990"></date>
<biblScope unit="volume">125</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="142">142</biblScope>
<biblScope unit="page" to="150">150</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><creation><date>1990</date>
</creation>
<langUsage><language ident="en">en</language>
</langUsage>
<abstract xml:lang="en"><p>The capacity to stimulate cytokine release may be important to the long-term effects of platelet-activating factor (PAF), which has a very short half-life. Previous studies have shown that PAF stimulates interleukin 1 (IL-1) release by human monocytes. IL-1 and other cytokines produced in response to PAF may be important to the long-term effects of this short-lived lipid. The THP-1 human monocytic leukemia cell line, was used to study the mechanism by which PAF stimulates IL-1 release. PAF stimulates the release of IL-1 β activity into THP-1 cell supernatants with a multiphasic dose-response curve very similar to that for monocytes. When THP-1 cells are treated with PAF and LPS in combination, these two stimuli interact synergistically to greatly increase the release of IL-1 activity. To assess the effect of PAF on IL-1 β synthesis, THP-1 cell pellet proteins were separated by SDS-PAGE, blotted, and immunostained to detect IL-1β. Immunostaining revealed that PAF increases intracellular IL-1 β precursor and that the combination of PAF and LPS increases IL-1 β precursor synergistically. PAF increases IL-1 β release mainly by increasing IL-1 β synthesis.</p>
</abstract>
</profileDesc>
<revisionDesc><change when="1990">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item><extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/86E1DF7906750C6C813B33AC7C8CCAF813C35A4C/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document><converted-article version="4.5.2" docsubtype="fla" xml:lang="en"><item-info><jid>YCIMM</jid>
<aid>90900694</aid>
<ce:pii>0008-8749(90)90069-4</ce:pii>
<ce:doi>10.1016/0008-8749(90)90069-4</ce:doi>
<ce:copyright type="unknown" year="1990"></ce:copyright>
</item-info>
<head><ce:title>Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin</ce:title>
<ce:author-group><ce:author><ce:given-name>Roger A.</ce:given-name>
<ce:surname>Barthelson</ce:surname>
<ce:cross-ref refid="AFF1"><ce:sup loc="post">a</ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="AFF2"><ce:sup loc="post">b</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>Thomas</ce:given-name>
<ce:surname>Potter</ce:surname>
<ce:cross-ref refid="AFF1"><ce:sup loc="post">a</ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="AFF2"><ce:sup loc="post">b</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:author><ce:given-name>Frank H.</ce:given-name>
<ce:surname>Valone</ce:surname>
<ce:cross-ref refid="AFF1"><ce:sup loc="post">a</ce:sup>
</ce:cross-ref>
<ce:cross-ref refid="AFF2"><ce:sup loc="post">b</ce:sup>
</ce:cross-ref>
</ce:author>
<ce:affiliation id="AFF1"><ce:label>a</ce:label>
<ce:textfn>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</ce:textfn>
</ce:affiliation>
<ce:affiliation id="AFF2"><ce:label>b</ce:label>
<ce:textfn>The University of California, San Francisco, California 94143 USA</ce:textfn>
</ce:affiliation>
</ce:author-group>
<ce:date-received day="29" month="6" year="1989"></ce:date-received>
<ce:date-accepted day="13" month="9" year="1989"></ce:date-accepted>
<ce:abstract class="author"><ce:section-title>Abstract</ce:section-title>
<ce:abstract-sec><ce:simple-para view="all" id="simple-para.0010">The capacity to stimulate cytokine release may be important to the long-term effects of platelet-activating factor (PAF), which has a very short half-life. Previous studies have shown that PAF stimulates interleukin 1 (IL-1) release by human monocytes. IL-1 and other cytokines produced in response to PAF may be important to the long-term effects of this short-lived lipid. The THP-1 human monocytic leukemia cell line, was used to study the mechanism by which PAF stimulates IL-1 release. PAF stimulates the release of IL-1 β activity into THP-1 cell supernatants with a multiphasic dose-response curve very similar to that for monocytes. When THP-1 cells are treated with PAF and LPS in combination, these two stimuli interact synergistically to greatly increase the release of IL-1 activity. To assess the effect of PAF on IL-1 β synthesis, THP-1 cell pellet proteins were separated by SDS-PAGE, blotted, and immunostained to detect IL-1β. Immunostaining revealed that PAF increases intracellular IL-1 β precursor and that the combination of PAF and LPS increases IL-1 β precursor synergistically. PAF increases IL-1 β release mainly by increasing IL-1 β synthesis.</ce:simple-para>
</ce:abstract-sec>
</ce:abstract>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6"><titleInfo lang="en"><title>Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin</title>
</titleInfo>
<titleInfo type="alternative" lang="en" contentType="CDATA"><title>Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin</title>
</titleInfo>
<name type="personal"><namePart type="given">Roger A.</namePart>
<namePart type="family">Barthelson</namePart>
<affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</affiliation>
<affiliation>The University of California, San Francisco, California 94143 USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Thomas</namePart>
<namePart type="family">Potter</namePart>
<affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</affiliation>
<affiliation>The University of California, San Francisco, California 94143 USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal"><namePart type="given">Frank H.</namePart>
<namePart type="family">Valone</namePart>
<affiliation>Department of Medicine, Veterans Administration Medical Center, 111k, 4150 Clement Street, San Francisco, California 94121 USA</affiliation>
<affiliation>The University of California, San Francisco, California 94143 USA</affiliation>
<role><roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1990</dateIssued>
<copyrightDate encoding="w3cdtf">1990</copyrightDate>
</originInfo>
<language><languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<abstract lang="en">Abstract: The capacity to stimulate cytokine release may be important to the long-term effects of platelet-activating factor (PAF), which has a very short half-life. Previous studies have shown that PAF stimulates interleukin 1 (IL-1) release by human monocytes. IL-1 and other cytokines produced in response to PAF may be important to the long-term effects of this short-lived lipid. The THP-1 human monocytic leukemia cell line, was used to study the mechanism by which PAF stimulates IL-1 release. PAF stimulates the release of IL-1 β activity into THP-1 cell supernatants with a multiphasic dose-response curve very similar to that for monocytes. When THP-1 cells are treated with PAF and LPS in combination, these two stimuli interact synergistically to greatly increase the release of IL-1 activity. To assess the effect of PAF on IL-1 β synthesis, THP-1 cell pellet proteins were separated by SDS-PAGE, blotted, and immunostained to detect IL-1β. Immunostaining revealed that PAF increases intracellular IL-1 β precursor and that the combination of PAF and LPS increases IL-1 β precursor synergistically. PAF increases IL-1 β release mainly by increasing IL-1 β synthesis.</abstract>
<relatedItem type="host"><titleInfo><title>Cellular Immunology</title>
</titleInfo>
<titleInfo type="abbreviated"><title>YCIMM</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo><publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">199001</dateIssued>
</originInfo>
<identifier type="ISSN">0008-8749</identifier>
<identifier type="PII">S0008-8749(00)X0294-8</identifier>
<part><date>199001</date>
<detail type="volume"><number>125</number>
<caption>vol.</caption>
</detail>
<detail type="issue"><number>1</number>
<caption>no.</caption>
</detail>
<extent unit="issue-pages"><start>1</start>
<end>272</end>
</extent>
<extent unit="pages"><start>142</start>
<end>150</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">86E1DF7906750C6C813B33AC7C8CCAF813C35A4C</identifier>
<identifier type="ark">ark:/67375/6H6-9VH08SWM-6</identifier>
<identifier type="DOI">10.1016/0008-8749(90)90069-4</identifier>
<identifier type="PII">0008-8749(90)90069-4</identifier>
<identifier type="ArticleID">90900694</identifier>
<recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource>
</recordInfo>
</mods>
<json:item><extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/document/86E1DF7906750C6C813B33AC7C8CCAF813C35A4C/metadata/json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/BernheimV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000918 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000918 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Psychologie |area= BernheimV1 |flux= Istex |étape= Corpus |type= RBID |clé= ISTEX:86E1DF7906750C6C813B33AC7C8CCAF813C35A4C |texte= Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin }}
This area was generated with Dilib version V0.6.33. |